Pioneering in omega-3
Our leadership is built on our global customer reach, our unique R&D capabilities for lipids, omega-3 derivates and development of omega-3 fatty acid formulations, as well as our unrivalled worldwide safety and efficacy data covering over 9 million patient years.
Our omega-3 expert team in Norway and experts around the globe are dedicated to developing the world's most effective and proven omega-3 solutions for a longer and healthier life. Our products improve and save lives everyday.
We created the omega-3 pharma market
Over 20 years ago with our drugs Omacor® and Lovaza® - the world’s first omega-3 fatty-acid-based drug for cardiovascular disease – we created the omega-3 pharma market. We pioneered the use of omega-3s as pharmaceuticals and successfully proved the potency of omega-3s in patients suffering from cardiovascular disease and developed the reference standard for prescription omega-3 ethyl ester 90 .
Turnkey solutions fitting your needs